Key Findings:  The authors conclude that while more clinical research is needed, and while in some cases results were mixed, in general, data indicate analgesic potentials for most cancer patients.
Type of Study:  Clinical Meta-analysis
Study Result:  Positive
Research Location(s):  Denmark
Year of Pub:  2023
Cannabinoids Studied:  Pharma THC:CBD
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype II
Route of Administration:  Sublingual/Oromucosal
Citation:  Christensen C, et al. Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients. J Clin Med. 2022; 12:(unknown pages). doi: 10.3390/jcm12010307
Authors:  Christensen C, Allesø M, Rose M, Cornett C